The Management of Metastatic Differentiated Thyroid Carcinoma

[1] Landis S.H., Murray T., Bolden S., Wingo P.A., Cancer statistics, 1999 CA Cancer, J Clin, 49, pp. 8-31, (1999)

[2] Sherman S.I., Brierley J.D., Sperling M., Et al., Prospective multicenter study of treatment of thyroid carcinoma initial analysis of staging and outcome, Cancer, 83, pp. 1012-1021, (1998)

[3] Schlumberger M.J., Papillary and follicular thyroid carcinoma, N Engl J Med, 338, pp. 297-306, (1998)

[4] Mazzaferri E.L., An overview of the management of papillary and follicular thyroid carcinoma, Thyroid, 9, pp. 421-427, (1999)

[5] Hay I.D., Klee G.G., Thyroid cancer diagnosis and management, Clin Lab Med, 13, pp. 725-734, (1993)

[6] Dinneen S.F., Valimaki M.J., Bergstralh E.J., Goellner J.R., Gorman C.A., Hay I.D., Distant metastases in papillary thyroid carcinoma 100 cases observed at one institution during 5 decades, J Clin Endocrinol Metab, 80, pp. 2041-2045, (1995)

[7] Vassilopoulou-Sellin R., Schultz P.N., Haynie T.P., Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy, Cancer, 78, pp. 493-501, (1996)

[8] Grebe S.K., Hay I.D., Thyroid cancer nodal metastases biologic significance and therapeutic considerations, Surg Oncol Clin N Am, 5, pp. 43-63, (1996)

[9] Simon D., Goretzki P.E., Witte J., Roher H.D., Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma, World J Surg, 20, pp. 860-866, (1996)

[10] McCaffrey T.V., Bergstralh E.J., Hay I.D., Locally invasive papillary thyroid carcinoma 1940-1990, Head Neck, 16, pp. 165-172, (1994)

[1] Landis S.H., Murray T., Bolden S., Wingo P.A., Cancer statistics, 1999 CA Cancer, J Clin, 49, pp. 8-31, (1999)

[2] Sherman S.I., Brierley J.D., Sperling M., Et al., Prospective multicenter study of treatment of thyroid carcinoma initial analysis of staging and outcome, Cancer, 83, pp. 1012-1021, (1998)

[3] Schlumberger M.J., Papillary and follicular thyroid carcinoma, N Engl J Med, 338, pp. 297-306, (1998)

[4] Mazzaferri E.L., An overview of the management of papillary and follicular thyroid carcinoma, Thyroid, 9, pp. 421-427, (1999)

[5] Hay I.D., Klee G.G., Thyroid cancer diagnosis and management, Clin Lab Med, 13, pp. 725-734, (1993)

[6] Dinneen S.F., Valimaki M.J., Bergstralh E.J., Goellner J.R., Gorman C.A., Hay I.D., Distant metastases in papillary thyroid carcinoma 100 cases observed at one institution during 5 decades, J Clin Endocrinol Metab, 80, pp. 2041-2045, (1995)

[7] Vassilopoulou-Sellin R., Schultz P.N., Haynie T.P., Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy, Cancer, 78, pp. 493-501, (1996)

[8] Grebe S.K., Hay I.D., Thyroid cancer nodal metastases biologic significance and therapeutic considerations, Surg Oncol Clin N Am, 5, pp. 43-63, (1996)

[9] Simon D., Goretzki P.E., Witte J., Roher H.D., Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma, World J Surg, 20, pp. 860-866, (1996)

[10] McCaffrey T.V., Bergstralh E.J., Hay I.D., Locally invasive papillary thyroid carcinoma 1940-1990, Head Neck, 16, pp. 165-172, (1994)